Detalhe da pesquisa
1.
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Blood
; 143(4): 336-341, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647641
2.
Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.
Blood
; 134(24): 2195-2208, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515253
3.
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition.
Blood
; 131(15): 1639-1653, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463564
4.
Novel epigenetic therapies in hematological malignancies: Current status and beyond.
Semin Cancer Biol
; 51: 198-210, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782607
5.
AML gets upSET when its dietary needs are unMet.
Blood
; 140(19): 2003-2004, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355468
6.
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.
Blood
; 129(2): 199-208, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793879
7.
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation.
J Thromb Thrombolysis
; 45(1): 106-113, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022213
8.
The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.
Br J Haematol
; 196(6): e55-e57, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993961
9.
JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.
Blood
; 124(9): 1492-501, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957147
10.
Laboratory and clinical risk assessment to treat myelodysplatic syndromes.
Clin Chem Lab Med
; 54(9): 1411-26, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26812791
11.
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation.
Blood
; 122(19): 3335-9, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24041577
12.
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma.
Anticancer Drugs
; 26(10): 1078-82, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26295869
13.
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function.
Ann Hematol
; 93(9): 1523-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711171
14.
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
J Thromb Thrombolysis
; 47(1): 155-156, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478722
15.
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Nat Cancer
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637657
16.
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia.
Sci Transl Med
; 15(685): eabn5135, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857430
17.
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.
Nat Commun
; 14(1): 2132, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059720
18.
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Clin Cancer Res
; 29(4): 711-722, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350312
19.
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.
Cancer Discov
; 13(7): 1720-1747, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012202
20.
Targeted therapy in haematological malignancies.
J Pathol
; 220(4): 404-18, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20041451